联合治疗对静脉曲张的临床反应:美国静脉注册研究分析
基于美国静脉注册静脉曲张模块的526例C2期患者数据,比较联合治疗(曲张静脉处理+大隐静脉消融)与单纯消融的疗效。联合治疗在疼痛和曲张静脉评分上显著优于单纯消融。
核心结论
- 对C2期慢性静脉功能不全的侵入性治疗可改善症状严重程度。
- 联合治疗可能比单纯大隐静脉消融更有效,尤其对选定患者。
研究设计与样本
- 美国静脉论坛2010年建立的美国静脉注册静脉曲张模块,收集48位医生5年数据。
- 分析526例CEAP C2期、未经治疗的患者,其中单纯消融97例,联合治疗429例。
- 联合治疗定义为直接处理可见曲张静脉(点式剥脱或硬化剂注射)联合大隐静脉消融。
- 单纯消融定义为仅大隐静脉消融(射频或激光)。
- 采用单变量统计和多变量线性回归模型评估VCSS变化。
临床怎么用
- 对于C2期静脉曲张患者,在消融静脉反流的基础上直接处理曲张静脉可能进一步改善症状。
- 联合治疗可作为选定患者优于单纯大隐静脉消融的治疗策略。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Varicose vein ablation procedures are being performed with increasing frequency; however, there is a lack of consensus on the relative efficacy of combined treatment of saphenous incompetence and symptomatic varicosities vs a staged approach. In this study, we examined the impact on symptom severity when a procedure to eliminate varicosities was added to standard endovenous saphenous ablation. METHODS: The Varicose Vein Module of the American Venous Registry was established by the American Venous Forum in 2010 and collected data from 48 physicians during a 5-year period. We analyzed patients with Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) C2 disease severity and without prior treatment. Combination therapy (CT) was defined as the use of a procedure directly addressing visible varicosities (stab phlebectomy or injection of sclerosant into varicosity) combined with endovenous saphenous vein ablation. Unimodal therapy (UT) was defined as endovenous saphenous vein ablation alone (radiofrequency or laser). Change in symptom severity was assessed by the pretreatment and 1-month follow-up Venous Clinical Severity Score (VCSS). Univariate statistics compared the CT and UT groups, with P values obtained using the Student t-test or Pearson χ2 test as appropriate. A multivariable linear regression model assessed the association of CT with the change in VCSS. RESULTS: There were 526 patients included for analysis (UT, 97; CT, 429). UT patients were more likely to be white (85.6% vs 62.7%; P < .001), had a higher initial VCSS (6.71 vs 5.07; P < .001), and were assessed at an earlier follow-up visit (28.9 days postoperatively vs 33.3 days; P < .001). Compared with UT, CT was associated with an additional half-point reduction in VCSS on univariate analysis (-3.71 points for UT vs -4.20 for CT; P = .13). After treatment, CT was associated with significantly lower scores on the pain and varicose vein components of the VCSS (pain: 0.31 for UT vs 0.07 for CT [P = .0008]; varicose veins: 0.47 for UT vs 0.03 for CT [P < .001]). On the multivariable model, after adjustment for white race, day of follow-up, age group, and initial VCSS, CT was associated with an additional reduction in VCSS of 1.52 points compared with UT (P = .002). CONCLUSIONS: Invasive treatment of C2 chronic venous insufficiency improves symptom severity. Whereas treatment of venous reflux is essential to address venous symptoms, our results suggest that patients further benefit from additional direct treatment of varicosities. For selected patients, CT may present a more effective treatment strategy than saphenous ablation alone.
引用
- Conway RG, Almeida JI, Kabnick L, et al. Clinical response to combination therapy in the treatment of varicose veins. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31843482. doi:10.1016/j.jvsv.2019.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。